DCX

DCX (PF3D7_0517800, apicortin) is a microtubule-associated protein of the apicomplexan cytoskeleton, defined by a doublecortin (DCX) domain and a partial p25-alpha domain both linked to microtubule binding and stabilization (PMID:19778640). Consistent with this predicted role, DCX binds P. falciparum α-tubulin-I and β-tubulin in vitro, and pharmacological disruption of this interaction with the p25-domain-binding drug Tamoxifen inhibits parasite growth and blood-stage progression (PMID:33633135). In P. berghei, DCX concentrates as a discrete ring-like structure at the apical end of invasive stages within the apical complex region (PMID:41545195). Functionally, reducing DCX levels in P. falciparum—via erythrocytic miR-150-3p/miR-197-5p-mediated knockdown—impairs parasite growth, invasion, and microneme (including AMA1) secretion, tying DCX to microneme-dependent host-cell invasion (PMID:32493727). However, clean genetic deletion of DCX in P. berghei produces no life-cycle defect, indicating the protein is dispensable and that redundant or compensatory mechanisms operate at the apical complex (PMID:41545195). Beyond tubulin binding, its precise molecular contribution at the apical complex has not been resolved in the available corpus.

1. 2009 Low

   Establishing whether PF3D7_0517800 could contribute to apicomplexan cytoskeleton, the finding predicted it as a microtubule-associated protein carrying two microtubule-binding domains.

   Evidence in silico domain analysis supported by independent proteomics

   PMID:19778640

   Open questions at the time

   • Computational prediction only, no direct biochemical validation in this paper
   • No demonstration of actual microtubule binding
   • No localization data
2. 2020 Medium

   To test whether DCX levels matter for parasite biology, miRNA-mediated knockdown showed that reduced DCX expression impairs growth, invasion, and micronemal/AMA1 secretion, linking DCX to microneme-dependent invasion.

   Evidence miRNA mimic loading into erythrocytes with invasion assays and Western blot for AMA1 secretion in P. falciparum cell-line model

   PMID:32493727

   Open questions at the time

   • Causal link is indirect through miRNA-mediated knockdown rather than direct DCX perturbation
   • No direct molecular interaction experiment
   • miRNAs may have off-target effects on other transcripts
3. 2021 Medium

   To move from predicted to demonstrated microtubule binding, binding assays showed DCX interacts with α-tubulin-I and β-tubulin, and disrupting this with Tamoxifen inhibited growth and blood-stage progression.

   Evidence in silico docking plus in vitro binding assays and pharmacological disruption with Tamoxifen in P. falciparum

   PMID:33633135

   Open questions at the time

   • No mutagenesis or reconstitution to confirm the binding interface
   • Tamoxifen may act on targets beyond DCX
   • Interaction shown in vitro, not confirmed in parasites
4. 2026 High

   To localize DCX and test its necessity, imaging placed it as a ring-like apical-complex structure, while clean genetic knockout showed it is dispensable across the P. berghei life cycle, revealing redundancy.

   Evidence live-cell imaging of GFP-tagged parasites, super-resolution/expansion microscopy, and gene deletion with full life-cycle phenotyping in P. berghei

   PMID:41545195

   Open questions at the time

   • Compensatory or redundant factors not identified
   • Apparent contradiction with P. falciparum knockdown phenotype unresolved (species difference vs. off-target)
   • Molecular function at the apical ring not defined

• The precise molecular role of DCX at the apical complex, and the identity of factors that render it dispensable in P. berghei despite an invasion-linked knockdown phenotype in P. falciparum, remain unknown.
• No mechanistic account reconciling the P. falciparum knockdown phenotype with the P. berghei knockout being phenotypically silent
• Redundant partners at the apical complex not identified
• No structural model of the DCX/p25-tubulin interaction